MYRX — Myrexis Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.24m
- -$0.97m
Annual cashflow statement for Myrexis, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2009 June 30th | 2010 June 30th | 2011 June 30th | 2012 June 30th | 2013 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -58.1 | -47 | -38.7 | -31.2 | -11.6 |
| Depreciation | |||||
| Non-Cash Items | 17.4 | 5.98 | 5.94 | 1.52 | 0.092 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -22.8 | -0.745 | -2.35 | 0.634 | -1.83 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -60.7 | -40.4 | -33.5 | -27.8 | -13 |
| Capital Expenditures | -0.375 | -2.13 | -0.093 | -0.055 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -7 | -52.3 | 14.9 | 27.2 | 71.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.38 | -54.4 | 14.8 | 27.1 | 71.3 |
| Financing Cash Flow Items | 196 | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 196 | 2.35 | 1.95 | 1.17 | -76.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 128 | -92.5 | -16.7 | 0.518 | -18.6 |